A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced nonヽlearヽell renal cell carcinoma

Post time 2026-7-23 23:58:47

journal：BJU International

Authors：Ciara Conduit; Ian D. Davis; Jeffrey C. Goh; Ganessan Kichenadasse; Howard Gurney; Carole A. Harris; David Pook; Laurence Krieger; Francis Parnis; Craig Underhill; Diana Adams; Felicia Roncolato; Anthony Joshua; Tom Ferguson; Prashanth Prithviraj; Michelle Morris; Michelle Harrison; Stephen Begbie; Elizabeth Hovey; Mathew George; Elizabeth C. Liow; Emma K. Link; Margaret McJannett; Craig Gedye; ;

Published date：2024-2-

DOI：10.1111/bju.16190

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bju.16190

Article link：https://doi.org/10.1111/bju.16190

Article Source：Wiley。

Remark：

Post time 2026-7-23 23:58:48

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced nonヽlearヽell renal cell carcinoma

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced nonヽlearヽell renal cell carcinoma Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced nonヽlearヽell renal cell carcinoma